Peer-Reviewed Publications

    The development of heat substation for drying waste heat utilisation

    Gariev, A. O.; Klemeš, J. J.; Kusakov, S. K.; Tovazhnyansky, L. L.; Anokhin, P.; Kapustenko, P. O.; Arsenyeva, O. P.; Čuček, L.
    Published
    Aug 20, 2014
    DOI
    10.3303/cet1439235
    Link to publication
    Summary

    The problem solution of waste heat utilization at the tobacco factory is considered in this work. The analysis of the possibility of waste heat utilization and appropriate calculations of plate heat exchangers were carried out. The method for multi component mixture condensation calculation is used. This allows obtaining optimal parameters for the working conditions of the heat exchangers according to the energy efficiency retrofit of industrial enterprises. The design of heat substation for waste heat utilisation was developed.

    Related Publications

    Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter

    Nicotine

    Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study

    Perception and Behavior;Smoke-free products

    The evolution of tobacco sales and use following the introduction of heated tobacco products in Japan

    Post-Market Studies and Surveillance Study

    Differences in Biomarkers of Potential Harm After 2+ Years of Tobacco Heating System Use Compared to Cigarette Smoking: A Cross-Sectional Study

    Smoke-free products;Clinical

    Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers

    Clinical Studies

    Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

    Clinical Studies

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.